Conhecimento de farmacêuticos sobre rinite alérgica e seu impacto na asma (guia ARIA para farmacêuticos): um estudo piloto comparativo entre Brasil e Paraguai
Knowledge of allergic rhinitis and its impact on asthma among pharmacists (ARIA guidelines for pharmacists): a comparative pilot study in Brazil and Paraguay
Marilyn Urrutia-Pereira; Raqueli Bittencourt; Carolina Fernandez; Alvaro A. Cruz; Laura Simon; Pietro Rianelli; Dirceu Solé
Resumo
Introdução: Os farmacêuticos, geralmente, são os primeiros profissionais a atenderem pacientes com rinite alérgica (RA). A guia ARIA (Rinite Alérgica e seu Impacto na Asma) estabelece padrões de melhores práticas para o manejo de pacientes com RA. Objetivo: Avaliar o nível de conhecimento sobre RA e a guia ARIA entre farmacêuticos do Brasil (BR) e Paraguai (PY). Método: 205 farmacêuticos (BR = 78, PY = 127) responderam ao questionário online autoaplicável (ARIA One Airways) sobre dados pessoais, profissionais e conhecimento sobre RA e guia ARIA, empregando o Google Forms. Resultados: A mediana de idade foi 32 anos, 35% BR e 52% PY referiam terem tido mais de quatro anos de treinamento. Embora reconheçam os principais sintomas de RA, 26% BR e 100% PY nunca perguntaram se o paciente tinha diagnóstico médico de RA; 20,5% BR e 100,0% PY se os sintomas ocorreram quando perto de animais ou alérgenos; 55% BR e 76% PY se o paciente tinha diagnóstico médico de asma; 59% BR e 70% PY se a rinite piora os sintomas de asma. Anti-histamínicos sedantes foram recomendados por 34,6% BR e 26,8% PY, e corticosteroides intranasais por 59% BR e 52% PY. Embora 85% BR e 100% PY desconheçam as diretrizes ARIA, 94,9% BR e 60,6% PY encaminhariam o paciente a um especialista. Conclusão: Embora os farmacêuticos sejam os primeiros profissionais procurados pelo paciente com RA para alívio de sintomas, o seu nível de conhecimento sobre RA e a guia ARIA é baixo. O seu treinamento para atingir melhor abordagem clínica é primordial.
Palavras-chave
Abstract
Introduction: Pharmacists are usually the first professionals to see patients with allergic rhinitis (AR). The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines establish best practice standards for the management of patients with AR. Objective: To evaluate the level of knowledge of AR and ARIA guideline recommendations among pharmacists in Brazil (BR) and Paraguay (PY). Method: A total of 205 pharmacists (BR = 78, PY = 127) answered a self-administered online questionnaire (ARIA One Airways), using the Google Forms tool, containing questions covering personal data, professional data, and knowledge of AR and ARIA guidelines. Results: Median age was 32 years; 35% BR and 52% PY reported having had more than four years of training. Although they recognized the main symptoms of AR, 26% BR and 100% PY never asked whether the patient had a medical diagnosis of AR; 20.5% BR and 100.0% PY if symptoms occurred when close to animals or allergens; 55% BR and 76% PY if the patient had a medical diagnosis of asthma; 59% BR and 70% PY if rhinitis worsened asthma symptoms. Sedating antihistamines were recommended by 34.6% BR and 26.8% PY, and intranasal corticosteroids by 59% BR and 52% PY. Although 85% BR and 100% PY were unaware of ARIA guidelines, 94.9% BR and 60.6% PY would refer the patient to a specialist. Conclusion: Even though pharmacists are the first professionals sought by patients with AR for symptom relief, their level of knowledge of AR and ARIA guidelines is very low. Training is paramount to improve clinical management of AR among pharmacists.
Keywords
References
1. Brozek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950‑8.
2. Urrutia-Pereira M, Solé D, Chong Neto HJ, Acosta V, Cepeda AM, et al. Sleep disorders in Latin-American children with asthma and/or allergic rhinitis and normal controls. Allergol Immunopathol (Madr). 2017;45(2):145-51.
3. Léger D, Annesi-Maesano I, Carat F, Rugina M, Chanal I, Pribil C, et al. Allergic rhinitis and its consequences on quality of sleep: An unexplored área. Arch Intern Med. 2006;18;166(16):1744-8.
4. Vandenplas O, D'Alpaos V, Van Brussel P. Rhinitis and its impact on work. Respir Med. 2010;104(4):497-503.
5. Bousquet J, van Cauwenberge P, Khaltaev N. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy Allergic Rhinitis and its Impact on Asthma. Allergy. 2004;59:373-87.
6. Canonica GW, Triggiani M, Senna G. 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients. Clin Mol Allergy. 2015;2;13:25.
7. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:S147‑S334.
8. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl 86):8-160.
9. Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126:466‑76.
10. Jorgenson D, Dalton D, Farrell B, Tsuyuki RT, Dolovich L. Guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott). 2013;146(6):342-52.
11. Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 201444(2):304-23.
12. Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol. 2013;160(4):393-400.
13. Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;30;6:47.
14. Bousquet J, Arnavielhe S, Bedbrook A, Fonseca J, Morais Almeida M, Todo Bom A, et al. The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life: The MASK study. Allergy. 2017;72(6):857-65.
15. Bousquet J, Bewick M, Arnavielhe S, Mathieu-Dupas E, Murray R, Bedbrook A, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017;72(10):1475-84.
16. Bousquet J, Arnavielhe S, Bedbrook A, Alexis-Alexandre G, van Eerd M, Murray R, et al. Treatment of allergic rhinitis using mobile technology with real world data: The MASK observational pilot study. Allergy. 2018 Jan 15. doi: 10.1111/all.13406. [Epub ahead of print].
17. Faleiros F, Kappler C, Pontes far, Silva SSC, Goes FSN, Cucik CD. Uso de Questionário online e divulgação virtual como estratégia de coleta de dados em estudos científicos. Texto Contexto Enferm. 2016;25(4):e3880014.
18. Price D, Scadding G, Ryan D, Bachert C, Canonica GW, Mullol J, et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilization survey. Clin Transl Allergy. 2015;5:39.
19. MotA Workshops. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy. 2004;59(4):373‑87.
20. Tan R, Cvetkovski B, Kritikos V, Price D, Yan K, Smith P, et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. Asthma Res Pract. 2017;3:8.
21. Stull DE, Roberts L, Frank L, Heithoff K. Relation of nasal congestion with sleep, mood and productivity. Curr Med Res Opin. 2007;23(4):811-9.
22. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med. 2005;4(6):439-46.
23. van der Molen T, van Boven JF, Maguire T, Goyal P, Altman P. Optimizing identification and management of f COPD patients - reviewing the role of the community pharmacist. Br J Clin Pharmacol. 2017;83(1):192-201.
24. Salim AM, Elgizoli B. Exploring self-perception of community pharmacists of their professional identity, capabilities, and role expansion. J Res Pharm Pract. 2016;5:116-20.
25. Lourenço O, Calado S, Sá-Sousa A, Fonseca J. Evaluation of allergic rhinitis and asthma control in a Portuguese community pharmacy setting. J Manag Care Spec Pharm. 2014;20(5):513-22.
26. Fromer LM, Blaiss MS, Jacob-Nara JA, Long RM, Mannion KM, Lauersen LA. Current allergic rhinitis experiences survey (CARES: Consumers' awareness, attitudes and practices. Allergy Asthma Proc. 2014;35(4):307-15.
27. Church MK, Maurer M, Simons FE, Bindslev-Jensen C, van Cauwenberge P, Bousquet J, et al. Risk of first-generation H1-antihistamines: a GA2 LEN position paper. Allergy. 2010;65:459‑66.
28. Staevska M, Gugutkova M, Lavarova C, Kralimarkova T, Dimitrov V, Zuberbier T, et al. Night-time sedating H1 antihistamine increases daytime sommnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Br J Dermatol. 2014;171:148-54.
29. Lombardi C, Mussico E, Rastrelli F, Bettoncelli G, Passalacqua G, Canonica GW. The patient with rhinitis in the pharmacy. A crosssectional study in real life. Asthma Res Pract. 2015;1:4.
30. Banerjee K, Mathie RT, Costelloe C, Howick J. Homeopathy for allergic rhinitis: a systematic review. J Altern Complement Med. 2017;23(6):426-44.
31. Pottie K, Haydt S, Farrell B, Kennie N, Sellors C, Martin C, et al. Pharmacist's identity development within multidisciplinary primary health care teams in Ontario; qualitative results from the IMPACT (+) project. Res Social Adm Pharm. 2009;5:319-26.
32. Barry AR, Pamment RT. Applying the guidelines for pharmacists integrating into primary care teams. Can Pharm J (Ott). 2016;149(4):219‑25.
33. Rosenthal MM, Austin Z, Tsuyuki RT. Barriers to pharmacy practice change: Is it our nature ou nurture? Can Pharm J (Ott). 2016;149(6):317‑9.
34. Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, et al. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy. 2015;70(11):1372-92.
Submitted date:
02/23/2018
Accepted date:
02/26/2018
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email